Your browser doesn't support javascript.
loading
Is NF-kappaB2/p100 a direct activator of programmed cell death?
Häcker, Hans; Karin, Michael.
Afiliação
  • Häcker H; Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. karinoffice@ucsd.edu
Cancer Cell ; 2(6): 431-3, 2002 Dec.
Article em En | MEDLINE | ID: mdl-12498710
ABSTRACT
Transcription factor NF-kappaB has been implicated in cancer development due to its ability to upregulate expression of genes with potentially prooncogenic functions, such as cell cycle regulators and antiapoptotic proteins (Karin et al., 2002). A recent report by suggests that a structural motif, a death domain (DD), present in one of the mammalian NF-kappaB proteins, NF-kappaB2/p100, allows it to directly activate cell death in a transcription-independent manner. Further, it is suggested that loss of the proapoptotic function of NF-kappaB2/p100 is directly linked to its oncogenic activity in lymphomas.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / NF-kappa B / Apoptose Limite: Animals / Humans Idioma: En Ano de publicação: 2002 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / NF-kappa B / Apoptose Limite: Animals / Humans Idioma: En Ano de publicação: 2002 Tipo de documento: Article